Northwire Canada EditionMonday, July 20, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

Healthcare

Page 125
  1. Sep 30, 2025 · 08:18 · SPLY

    Safe Supply Streaming Co Ltd. and MDBio Sign U.S. Manufacturing Agreement for ToxiShield Products Amidst Record Federal Overdose Crisis Funding

    Safe Supply Streaming Co Ltd. and MDBio Sign U.S. Manufacturing Agreement for ToxiShield Products Amidst Record Federal Overdose Crisis Funding

    01
  2. Sep 30, 2025 · 07:00 · BHC

    Bausch Health to Announce Third Quarter 2025 Results on October 29

    Bausch Health to Announce Third Quarter 2025 Results on October 29

    02
  3. Sep 29, 2025 · 18:39 · BUX

    Biomark obtains Asia patents for lung cancer test

    Biomark obtains Asia patents for lung cancer test

    03
  4. Sep 29, 2025 · 17:30 · JNH

    Jack Nathan Health Announces Its Q2 Fiscal 2026 Financial Results

    Jack Nathan Health Announces Its Q2 Fiscal 2026 Financial Results

    04
  5. Sep 29, 2025 · 17:00 · EPRX

    Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs

    Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs

    05
  6. Sep 29, 2025 · 12:37 · BNXT

    Bionxt sends cladribine API to CDMO partner

    Bionxt sends cladribine API to CDMO partner

    06
  7. Sep 29, 2025 · 08:31 · BUX

    BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy

    BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy

    07
  8. Sep 29, 2025 · 08:00 · BIOV

    BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")

    BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")

    08
  9. Sep 28, 2025 · 03:06 · ONCO

    Onco, Nucro begin lab work under IND enabling program

    Onco, Nucro begin lab work under IND enabling program

    09
  10. Sep 26, 2025 · 20:50 · NGMD

    Nugen's EziAutoJector receives NHS drug tariff approval

    Nugen's EziAutoJector receives NHS drug tariff approval

    10
  11. Sep 26, 2025 · 17:25 · OTC

    Ocumetics Technology has success in Mexico City

    Ocumetics Technology has success in Mexico City

    11
  12. Sep 26, 2025 · 17:04 · METX

    ME obtains U.S. patent for G-CSF antibody candidate

    ME obtains U.S. patent for G-CSF antibody candidate

    12
  13. Sep 26, 2025 · 16:38 · VITA

    Vitalist extends debenture maturity date to 2027

    Vitalist extends debenture maturity date to 2027

    13
  14. Sep 25, 2025 · 12:38 · AGN

    Algernon obtains $4M financing for Alzheimer's clinics

    Algernon obtains $4M financing for Alzheimer's clinics

    14
← Newer Older →